Johan Vekemans

Active 2001–2025

71
Papers
18,039
Citations
57
h-index
70
i10-index

Citations

Citations per year for Johan Vekemans1974: 1 citations1986: 1 citations2001: 2 citations2002: 20 citations2003: 23 citations2004: 31 citations2005: 29 citations2006: 26 citations2007: 23 citations2008: 39 citations2009: 68 citations2010: 61 citations2011: 98 citations2012: 68 citations2013: 78 citations2014: 62 citations2015: 69 citations2016: 51 citations2017: 149 citations2018: 64 citations2019: 429 citations2020: 500 citations2021: 2,198 citations2022: 1,441 citations2023: 511 citations2024: 553 citations2025: 184 citations2026: 7 citations1975–1985: no citations, so these years are not shown1987–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,809 citing papers, 18.9% of this breakdownUnited Kingdom: 1,107 citing papers, 11.6% of this breakdownChina: 424 citing papers, 4.4% of this breakdownGermany: 393 citing papers, 4.1% of this breakdownAustralia: 376 citing papers, 3.9% of this breakdownItaly: 297 citing papers, 3.1% of this breakdownIndia: 295 citing papers, 3.1% of this breakdownNetherlands: 288 citing papers, 3% of this breakdownCanada: 287 citing papers, 3% of this breakdownFrance: 278 citing papers, 2.9% of this breakdownSwitzerland: 236 citing papers, 2.5% of this breakdownBelgium: 215 citing papers, 2.2% of this breakdown
0%18.9%Other 37.3%

Fields

  • Medicine79.2%
  • Immunology and Microbiology8.8%
  • Biochemistry, Genetics and Molecular Biology4.3%
  • Social Sciences2.8%
  • Mathematics1.9%
  • Computer Science0.5%
  • Other2.5%

Topics

  • SARS-CoV-2 and COVID-19 Research17.3%
  • COVID-19 Clinical Research Studies7.9%
  • Vaccine Coverage and Hesitancy5.6%
  • vaccines and immunoinformatics approaches3.5%
  • Malaria Research and Control3.4%
  • Immune responses and vaccinations3.1%
  • Other59.2%

Coauthors

All papers

Open in search
  1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Hill, Helen Hill, Ian Hirsch, Susanne H. Hodgson, Alane Izu, Susan Jackson, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Alison M. Lawrie, Alice Lelliott, Vincenzo Libri, Patrick Lillie, Raburn M. Mallory, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Hazel Morrison, Yama F Mujadidi, Anusha Nana, Peter O’Reilly, Sherman D. Padayachee, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Sarah Rhead, Alexandre Vargas Schwarzbold, Nisha Singh, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Richard Tarrant, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Marion Watson, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Fatola Abayomi, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Yemi Adelaja, Gbadebo Adewetan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Thamires C. D. S. C Almeida and 665 more - The Lancet 2020 cited by 5,010

  2. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy Beveridge, Kevin R. Bewley, Phillip J. Brown, Emily Brunt, Karen R. Buttigieg, Susana Camara, Sue Charlton, Emily Chiplin, Paola Cicconi, Elizabeth Clutterbuck, Andrea M. Collins, Naomi S. Coombes, Sue Ann Costa Clemens, M. Davison, Tesfaye Demissie, Tanya Dinesh, Alexander D. Douglas, C.J. Duncan, Katherine R. W. Emary, Katie Ewer, Sally Felle, Daniela M. Ferreira, Adam Finn, Pedro M. Folegatti, Ross Fothergill, Sara Fraser, Harriet Garlant, Laura Gatcombe, Kerry Godwin, Anna L. Goodman, Christopher Green, Bassam Hallis, Thomas C. Hart, Paul T. Heath, Helen Hill, Adrian V. S. Hill, Daniel Jenkin, Mwila Kasanyinga, Simon Kerridge, Chanice Knight, Stephanie Leung, Vincenzo Libri, Patrick Lillie, Spyridoula Marinou, Joanna McGlashan, Alastair McGregor, Lorna McInroy, Angela M. Minassian, Yama F Mujadidi, Elizabeth J. Penn, Christos J. Petropoulos, Katrina M. Pollock, Pamela C. Proud, Samuel Provstgaard-Morys, Durga Rajapaska, Maheshi Ramasamy, Katherine Sanders, Imam H. Shaik, Nisha Singh, Andrew Smith, Matthew D. Snape, Rinn Song, Sonu Shrestha, Rebecca Sutherland, Emma C. Thomson, David P. J. Turner, Alice Webb-Bridges, Terri Wrin, Christopher J. Williams - Nature Medicine 2021 cited by 1,239

  3. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Green, Christopher Green, Melanie Greenland, Catherine Hill, Helen Hill, Ian Hirsch, Alane Izu, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Vincenzo Libri, Patrick Lillie, Natalie G. Marchevsky, Richard P. Marshall, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Yama F Mujadidi, Anusha Nana, Sherman D. Padayachee, Daniel J. Phillips, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Adam Ritchie, Hannah Robinson, Alexandre Vargas Schwarzbold, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Thomas White, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Gbadebo Adewatan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Felipe B. Alvernaz, Fabio Santos Amorim, Claudia Sala Andrade, Foteini Andritsou, Rachel Anslow and 666 more - The Lancet 2021 cited by 1,208

  4. Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2017 cited by 536

  5. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Subradeep Majumder - Clinical Infectious Diseases 2017 cited by 550

  6. Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Santhanam Sridhar, Betuel Sigaúque, Greg Tyrrell, Vinod K. Paul - Clinical Infectious Diseases 2017 cited by 453

  7. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis Bont - The Lancet Infectious Diseases 2018 cited by 474

  8. Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Norman C. Waters, Ashley J. Birkett, David C. Kaslow, W. Ripley Ballou, Christian F. Ockenhouse, Johan Vekemans - The Journal of Infectious Diseases 2016 cited by 230

  9. Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework

    Authors: , , , , , , , , , , - Clinical Infectious Diseases 2021 cited by 127

  10. Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evans Antwi, Kelvin Onoka, Kevin K'Orimba, Paul Ndaya Oloo, Elizabeth Leakey, Emilia Gvozdenović, Cristina Cravcenco, Pascale Vandoolaeghe, Johan Vekemans, Karen Ivinson - The Lancet Infectious Diseases 2022 cited by 72

  11. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bassam Hallis, Paul T. Heath, Jodie Hay, Helen Hill, Daniel Jenkin, Simon Kerridge, Rajeka Lazarus, Vincenzo Libri, Patrick Lillie, Catherine Ludden, Natalie G. Marchevsky, Angela M. Minassian, Alastair McGregor, Yama F Mujadidi, Daniel J. Phillips, Emma Plested, Katrina M. Pollock, Hannah Robinson, Darren Smith, Rinn Song, Matthew D. Snape, Rebecca Sutherland, Emma C. Thomson, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Christopher J. Williams, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Merryn Voysey, Maheshi Ramasamy, Andrew J. Pollard - The Lancet 2021 cited by 651

  12. Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses

    Authors: , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2017 cited by 232

  13. The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2019 cited by 173

  14. Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alberto Berardi, Indi Trehan, Georgia Leigh Macad, Miha Lučovnik, Claire Oluwalana, Pippa Letchworth, Martin Jagoutz-Herzlinger, Francis G. Muriithi, Kouther Issa Yassen, Gerard H.A. Visser, Sophie Cooper - Clinical Infectious Diseases 2017 cited by 207

  15. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela M. Minassian, Rebecca Ashfield, Nicola K. Viebig, Fay L. Nugent, Alexander D. Douglas, Johan Vekemans, Gavin J. Wright, Saul N. Faust, Adrian V. S. Hill, Carole A. Long, Alison M. Lawrie, Simon J. Draper - JCI Insight 2017 cited by 153

  16. Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2017 cited by 141

  17. Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses

    Authors: , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2017 cited by 195

  18. From the circumsporozoite protein to the RTS,S/AS candidate vaccine

    Authors: , , , - Human Vaccines 2010 cited by 258

  19. A Field Trial to Assess a Blood-Stage Malaria Vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carter L. Diggs, Brent House, David E. Lanar, Sheetij Dutta, D. Gray Heppner, Christopher V. Plowe - New England Journal of Medicine 2011 cited by 367

  20. Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2017 cited by 133

  21. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS neglected tropical diseases 2016 cited by 133

  22. Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016

    Authors: , , , , - Vaccine 2017 cited by 75

  23. Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chunla He, Walter L. Straus, Kellie J. MacPhee, Isabel Regadas, Diana Nyabundi, Ruth Chirchir, Omu Anzala, John Kimotho, Caleb K. Kibet, Kelli Greene, Hongmei Gao, Erica L. Beatman, K Benson, Dominick J. Laddy, David M. Brown, Rhianna Bronson, Jalen Baptiste, Suprabhath Gajjala, Zahra Rikhtegaran Tehrani, Alison Benner, Mukundhan Ramaswami, Danny Lu, Nushin Alavi, Sonya Amirzehni, Michael Kubitz, Ryan Tingle, Erik Georgeson, Nicole Phelps, Yumiko Adachi, Alessia Liguori, Claudia Flynn, Katherine McKenney, Xiaoya Zhou, D. Collins Owuor, Sharon Owuor, S Kim, Michael Duff, Ju Yeong Kim, Grace Gibson, Sabyasachi Baboo, Jolene K. Diedrich, Torben Schiffner, Marisa Shields, Mabela Matsoso, Jairo Ivo dos Santos, Kristen Syvertsen, Allison Kennedy, Melissa Schroeter, Johan Vekemans, John R. Yates, James C. Paulson, Ollivier Hyrien, Adrian B. McDermott, Pholo Maenetje, Julien Nyombayire, Etienne Karita, Rosine Ingabire, Vinodh Edward, Vincent Muturi‐Kioi, Janine Maenza, Adrienne E. Shapiro, M. Juliana McElrath, Srilatha Edupuganti, Barbara S. Taylor, David Diemert, Gabriel Ozorowski, Richard A. Koup, David C. Montefiori, Andrew B. Ward, Gunilla B. Karlsson Hedestam and 8 more - Science 2025 cited by 60

  24. Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James McCarthy, Carter L. Diggs, Johan Vekemans, Carole A. Long, Adrian V. S. Hill, Alison M. Lawrie, Sheetij Dutta, Simon J. Draper - The Journal of Infectious Diseases 2016 cited by 115